Kristian Helin
Fondateur chez University of Copenhagen
Profil
Kristian Helin is the founder of Dania Therapeutics ApS (2021) and EpiTherapeutics ApS (2008).
At EpiTherapeutics ApS, he held the title of Principal from 2008 to 2010.
Dr. Helin also worked as a Divisional Director at Istituto Europeo di Oncologia SRL.
Dr. Helin is also the founder of the University of Copenhagen, Danish National Research Foundation.
Postes actifs de Kristian Helin
| Sociétés | Poste | Début |
|---|---|---|
| University of Copenhagen | Fondateur | - |
| Danish National Research Foundation | Fondateur | - |
Anciens postes connus de Kristian Helin
| Sociétés | Poste | Fin |
|---|---|---|
Istituto Europeo di Oncologia SRL
 Istituto Europeo di Oncologia SRL Hospital/Nursing ManagementHealth Services Istituto Europeo di Oncologia SRL is a holding company, which operates oncology hospitals. It offers healthcare services, basic and translational cancer research, and PhD and post doctoral programs in molecular medicine. The company was founded by Umberto Veronesi on May 30, 1994 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Health Technology |
Istituto Europeo di Oncologia SRL
Istituto Europeo di Oncologia SRL Hospital/Nursing ManagementHealth Services Istituto Europeo di Oncologia SRL is a holding company, which operates oncology hospitals. It offers healthcare services, basic and translational cancer research, and PhD and post doctoral programs in molecular medicine. The company was founded by Umberto Veronesi on May 30, 1994 and is headquartered in Milan, Italy. | Health Services |
| Danish National Research Foundation |